Molecular pathology in real time.

Area of Science:

• Oncology
• Pathology
• Molecular Diagnostics

Background:

• Morphological tumor characterization alone is insufficient for modern individualized therapy.
• Targeted therapies require molecular analysis for predictive marker detection.
• Intratumor heterogeneity poses challenges in cancer diagnostics and treatment.

Purpose of the Study:

• To highlight the impact of tumor heterogeneity on pathological diagnosis and targeted therapy.
• To discuss the limitations of biopsy samples in capturing tumor molecular profiles.
• To explore strategies for overcoming challenges posed by intratumor heterogeneity.

Main Methods:

• Review of current challenges in cancer diagnostics due to tumor heterogeneity.
• Discussion of the influence of intratumor heterogeneity on predictive marker detection.
• Exploration of advanced diagnostic and molecular analysis techniques.

Main Results:

• Limited biopsy samples may not be representative of the entire tumor, leading to inaccurate marker detection.
• Discordance between primary tumor and metastatic disease molecular features can cause treatment failure.
• Tumor heterogeneity necessitates a re-evaluation of pathological diagnostic approaches.

Conclusions:

• Pathological diagnosis must integrate molecular analysis to account for tumor heterogeneity.
• Strategies like examining larger tissue samples or using sensitive molecular methods are needed.
• Detecting molecular alterations in circulating tumor DNA offers a promising solution to address heterogeneity.